Functional responses and molecular mechanisms involved in histone-mediated platelet activation

Thrombosis and Haemostasis

Volumn 110, Issue 5, 2013, Pages 1035-1045

  Carestia, Agostina ^a   Rivadeneyra, Leonardo ^a   Romaniuk, María Albertina ^a   Fondevila, Carlos ^b   Negrotto, Soledad ^a   Schattner, Mirta ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b Interventional Cardiology Department   (Argentina)

Author keywords

Histones; Inflammation; Neutrophil extracellular traps; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; HISTONE; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN KINASE B; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; BINDING ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; FIBRINOGEN METABOLISM; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; PLATELET SPREADING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBIN GENERATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

HISTONES; INFLAMMATION; NEUTROPHIL EXTRACELLULAR TRAPS; PLATELETS;

BLOOD PLATELETS; BUTADIENES; CELL ADHESION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRINOGEN; HEMOSTASIS; HISTONES; HUMANS; NF-KAPPA B; NITRILES; P-SELECTIN; PLATELET ACTIVATION; SIGNAL TRANSDUCTION; SULFONES; THROMBIN;

EID: 84886999631     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-02-0174     Document Type: Article

References (37)

1. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13: 34-45.
2. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010; 328: 562-564.
3. Lindemann S, Kramer B, Seizer P, et al. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007; 5 (Suppl 1): 203-211.
4. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999; 81: 1-7.
5. Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-469.
6. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
7. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007; 5: 577-582.
8. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-241.
9. Luger K, Mader AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2. 8 A resolution. Nature 1997; 389: 251-260.
10. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15: 1318-1321.
11. Zeerleder S, Zwart B, Wuillemin WA, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947-1951.
12. Massberg S, Grahl L, von Bruehl ML, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16: 887-896.
13. von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
14. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011; 118: 1952-1961.
15. Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010; 2: e2010024.
16. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107: 15880-15885.
17. Romaniuk MA, Tribulatti MV, Cattaneo V, et al. Human platelets express and are activated by galectin-8. Biochem J 2010; 432: 535-547.
18. Negrotto S, Malaver E, Alvarez ME, et al. Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli. J Pharmacol Exp Ther 2006; 319: 972-979.
19. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011; 118: 3708-3714.
20. Brill A, Fuchs TA, Savchenko A, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012; 10: 136-144.
21. Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-1422.
22. Sabroe I, Parker LC, Wilson AG, et al. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin Exp Allergy 2002; 32: 984-989.
23. Malaver E, Romaniuk MA, D'Atri LP, et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost 2009; 7: 1333-1343.
24. Borsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997; 245: 751-759.
25. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273: 18623-18632.
26. Vlahos CJ, Matter WF, Hui KY, et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269: 5241-5248.
27. Arents G, Moudrianakis EN. The histone fold: a ubiquitous architectural motif utilized in DNA compaction and protein dimerization. Proc Natl Acad Sci USA 1995; 92: 11170-11174.
28. Marino-Ramirez L, Hsu B, Baxevanis AD, et al. The Histone Database: a comprehensive resource for histones and histone fold-containing proteins. Proteins 2006; 62: 838-842.
29. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2005; 25: 1321-1324.
30. Allam R, Scherbaum CR, Darisipudi MN, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012; 23: 1375-1388.
31. Gonias SL, Pasqua JJ, Greenberg C, et al. Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3. Thromb Res 1985; 39: 97-116.
32. Rivera J, Lozano ML, Navarro-Nunez L, et al. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009; 94: 700-711.
33. Bishop-Bailey D. The platelet as a model system for the acute actions of nuclear receptors. Steroids 2010; 75: 570-575.
34. Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-2671.
35. Medina C, Harmon S, Inkielewicz I, et al. Differential inhibition of tumour cellinduced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. Br J Pharmacol 2012; 166: 938-949.
36. Huang H, Evankovich J, Yan W, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54: 999-1008.
37. Pacienza N, Pozner RG, Bianco GA, et al. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB J 2008; 22: 1113-1123.